Key Insights - The report highlights the growth in the active bond fund sector, with a total of 3,263 funds and a total scale of 7.90 trillion yuan, reflecting a 1.0% increase quarter-on-quarter [7][8] - The performance of active bond funds showed mixed results, with short-term pure bond funds performing well due to rising government bond yields, while mixed secondary bond funds saw increased volatility [7][8] - The report indicates a shift in asset allocation within bond funds, with a decrease in bond positions and an increase in equity positions, particularly in sectors like non-ferrous metals and pharmaceuticals [8] Group 1: Active Bond Fund Overview - As of the end of Q1 2025, the number of active bond funds increased by 0.8% compared to the previous quarter, while the total fund scale rose by 1.0% [7] - In Q1 2025, 43 new active bond funds were issued, totaling 783.7 billion yuan, which is a 16.7% decrease from the previous quarter [7] - The issuance of medium to long-term pure bond funds decreased by 31.5%, while mixed secondary bond funds saw a 65.1% increase in issuance [7] Group 2: Company-Specific Insights - For Mindray Medical (300760.SZ), the company reported a revenue of 36.726 billion yuan in 2024, a year-on-year increase of 5.14%, with a net profit of 11.668 billion yuan, up 0.74% [9][10] - The company’s international business grew by 21.28%, accounting for approximately 45% of total revenue, indicating a strong international expansion strategy [11] - The report anticipates a recovery in domestic business by Q3 2025, despite a significant year-on-year decline in Q1 2025 [11] Group 3: Industry Trends - The report on Haibo Technology (688411.SH) indicates a revenue of 8.270 billion yuan in 2024, a growth of 18.44%, with a focus on energy storage systems [14][15] - The company’s energy storage product output and sales saw significant increases, with a 35.40% rise in production and a 90.19% increase in sales [15] - The report emphasizes the company’s leading position in the domestic energy storage market and its successful international partnerships [17] Group 4: Financial Performance - For Sanmei Co., Ltd. (603379.SH), the company achieved a revenue of 4.040 billion yuan in 2024, a 21.17% increase, with a net profit growth of 178.40% [24][25] - The report highlights the impact of rising refrigerant prices and strong demand from the home appliance and automotive sectors on the company’s financial performance [25][26] - The company is expected to maintain strong performance due to favorable supply-demand dynamics in the refrigerant market [28] Group 5: Future Outlook - The report suggests that the domestic medical device market, particularly for Mindray Medical, is poised for recovery, with expectations of improved performance in 2025 [11][12] - Haibo Technology is projected to continue its growth trajectory, supported by its strong market position and international expansion efforts [17][18] - Sanmei Co., Ltd. is expected to benefit from ongoing demand in the refrigerant market, with projections for significant profit growth in the coming years [28]

Investment Rating - The report maintains an "Outperform" rating for the fluorochemical industry [8][9]. Core Insights - The fluorochemical industry is expected to benefit from the upcoming peak season for refrigerants driven by summer heat, with active trading in a low inventory context [2][8]. - The report highlights a significant increase in refrigerant prices, with R32 reaching 48,000 yuan/ton, reflecting a month-on-month increase of 1,000 yuan/ton [2][24]. - The implementation of the Montreal Protocol's national plan is expected to tighten supply and enhance the long-term outlook for refrigerant prices, particularly for R22 and R32 [4][56]. Summary by Sections 1. April Fluorochemical Industry Performance - As of April 28, 2025, the fluorochemical index stood at 1,232.89 points, down 2.60% from March, outperforming the Shenwan Chemical Index by 0.63 percentage points [1][16]. 2. April Refrigerant Market Review 2.1 Refrigerant Price and Spread Performance - Prices for refrigerants have shown an upward trend, with R32 and R410a experiencing significant month-on-month increases of 14% and 9% respectively in March [22][24]. - The report notes that R22 prices are stable at 36,000 yuan/ton, while R134a remains at 47,000 yuan/ton [24]. 2.2 Refrigerant Export Data Tracking - In Q1 2025, R32 exports increased by 5.3% year-on-year, while R22 exports decreased by 38.4% [31]. - March saw a significant rebound in export volumes, with R22 and R32 experiencing month-on-month growth of 165% and 150% respectively [31][32]. 2.3 Major Refrigerant Operating Rates and Production Data Tracking - The report indicates that production quotas for R22 have been reduced by 28% compared to 2024, reflecting tighter supply constraints [58]. 3. Implementation of the Montreal Protocol National Plan - The national plan aims to reduce HCFCs production and usage by 67.5% and 73.2% respectively by 2025, with a complete phase-out by 2030 [4][56]. - The report emphasizes the ongoing commitment to reducing HFCs, with a target of a 10% reduction by 2029 [4][56]. 4. Air Conditioning/Automobile/Refrigerator Production and Export Data Tracking 4.1 Air Conditioning - The report notes a continuous year-on-year increase in air conditioning production for Q2 2025, with domestic production expected to rise significantly [5][65]. 5. Key Company Profit Forecasts and Investment Ratings - Key companies such as Juhua Co., Dongyue Group, and Sanmei Co. are highlighted as having strong profit growth prospects, with Juhua Co. expected to achieve a net profit of 1.52 yuan per share in 2025 [9].

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company reported a significant increase in net profit for Q1 2025, driven by the high demand for refrigerants, with a year-on-year growth of 161% [1] - The refrigerant market is expected to remain strong, supported by demand from downstream sectors such as air conditioning and automotive [4] - The company is projected to achieve net profits of 41 billion, 53 billion, and 61 billion RMB for the years 2025 to 2027, respectively, indicating a robust growth trajectory [5] Revenue and Profitability - In Q1 2025, the company achieved total revenue of 5.8 billion RMB, a year-on-year increase of 6% [1] - The company's gross profit margin improved to 28.4%, reflecting a year-on-year increase of 13.7 percentage points [3] - The earnings per share (EPS) for 2025 is estimated at 1.52 RMB, with a projected growth in EPS for the following years [5] Market Performance - The average price of refrigerants has increased, with R22, R32, R125, and R134a prices rising by 9%, 13%, 7%, and 11% respectively since the beginning of the year [4] - The company's market capitalization is approximately 68.47 billion RMB, with a target price set at 31.92 RMB [9] Segment Performance - The refrigerant segment saw a year-on-year sales increase of 4%, despite a seasonal decline in Q1 [2] - The fluoropolymer segment faced temporary pressure, with a year-on-year sales decline of 7% [2] - The basic chemical products segment benefited from improved caustic soda prices, leading to a revenue increase of 7% year-on-year [3]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5][14] Core Views - The company achieved a revenue of 4.04 billion yuan in 2024, representing a year-on-year increase of 21.17%, and a net profit attributable to shareholders of 779 million yuan, up 178.40% year-on-year [5][6] - The first quarter of 2025 saw a revenue of 1.21 billion yuan, a 26.42% increase year-on-year, with a net profit of 401 million yuan, reflecting a 159.59% year-on-year growth [5][6] - The report anticipates continued growth in the refrigerant market, with profit forecasts for 2025-2027 being adjusted upwards, expecting net profits of 2.08 billion, 2.61 billion, and 2.97 billion yuan respectively [5][6] - The company plans to implement a mid-term dividend in 2025, with a cash dividend ratio of no more than 20% of the net profit attributable to shareholders for that period [7] Financial Performance Summary - In 2024, the company sold 125,400 tons of fluorinated refrigerants, generating a revenue of 3.27 billion yuan, with an average price of 26,056 yuan per ton [6] - The first quarter of 2025 showed a decline in sales volume for fluorinated refrigerants but a significant increase in average price, with a 43.5% rise compared to the average price in 2024 [6] - The company’s gross profit margin is projected to increase from 29.8% in 2024 to 48.9% in 2025, indicating improved profitability [9][11] Dividend and Employee Stock Plan - The company announced a cash dividend of 0.45 yuan per share for 2024, with a payout ratio of 35.07% [7] - An employee stock ownership plan was introduced, allowing for the purchase of up to 372,310 shares at a price of 20.47 yuan per share, aimed at enhancing employee confidence [7]

Group 1 - The core viewpoint of the news is that the 中证500质量成长指数 has shown a slight decline, with mixed performance among its constituent stocks, indicating a volatile market environment [1][2] - The 500 Quality Growth ETF has experienced a significant increase in shares, with a growth of 5 million shares this month, ranking it in the top third among comparable funds [1][2] - The top ten weighted stocks in the 中证500质量成长指数 account for 24.26% of the index, highlighting the concentration of investment in a few key companies [2] Group 2 - The short-term international economic outlook remains uncertain, but domestic policies and resilient internal demand are expected to support the A-share market's relative advantage over overseas markets [2] - The mid-term focus is on the AI technology revolution and self-sufficiency, with recommendations to pay attention to domestic technology and consumption sectors benefiting from policy support [2] - The 500 Quality Growth ETF closely tracks the 中证500质量成长指数, which selects 100 companies with high profitability, sustainable earnings, and strong cash flow from the 中证500 index [2]

Core Viewpoint - The company is experiencing significant growth in net profit due to the rapid increase in refrigerant prices, with substantial year-on-year increases projected for 2024 and Q1 2025 [1][2] Financial Performance - In 2024, the company achieved operating revenue of 4.04 billion yuan, a year-on-year increase of 21.17% [1] - The net profit attributable to shareholders for 2024 was 779 million yuan, up 178.40% year-on-year [1] - For Q1 2025, the company reported operating revenue of 1.21 billion yuan, a 26.42% increase year-on-year [1] - The net profit attributable to shareholders for Q1 2025 was 401 million yuan, reflecting a year-on-year growth of 159.59% [1] Refrigerant Market Dynamics - The company's refrigerant sales volume reached 125,400 tons in 2024, a 1.65% increase year-on-year [2] - The average selling price of refrigerants for 2024 was 26,100 yuan per ton, up 28.17% year-on-year [2] - In Q1 2025, the average selling price of refrigerants rose to 37,400 yuan per ton, marking a 56.92% year-on-year increase [2] - The supply quotas for second-generation refrigerants have been significantly reduced, with R22 quotas down by 18% and R142b by 64% [2] Price Trends - As of April 28, 2025, the price of R32 was 48,000 yuan per ton, with a price difference of 32,970 yuan per ton, reflecting a 3% increase [3] - The price of R22 remained stable at 36,000 yuan per ton, with no change in price difference [3] - R134a and R152a also saw price increases of 1% and 6% respectively compared to early April [3] Strategic Investments - The company is actively investing in the fluorinated refrigerants, fluorochemical products, and fluoropolymers sectors [4] - Projects include a lithium hexafluorophosphate production facility with an annual capacity of 6,000 tons and a fluoropolymer project with a capacity of 5,000 tons [4] - The company is also advancing various technological and infrastructure projects to enhance its production capabilities [4] Future Outlook - The company is expected to benefit from the ongoing structural reforms in the supply side of the refrigerant market, leading to a more concentrated competitive landscape [6] - Projected net profits for 2025-2027 are 1.598 billion, 1.844 billion, and 1.959 billion yuan respectively, with year-on-year growth rates of 105.3%, 15.4%, and 6.2% [6] - The diluted EPS for the same period is forecasted to be 2.62, 3.02, and 3.21 yuan, with corresponding PE ratios of 16.3, 14.1, and 13.3 [6]

| 指数 | 收盘 | | 涨跌（％） | | | --- | --- | --- | --- | --- | | 名称 | （点） | 1 日 | 5 日 | 1 月 | | 上证指数 | 3288 | -0.2 | -1.8 | -0.09 | | | | | 8 | | | 深证综指 | 1898 | -0.9 | -6.3 | -0.68 | | 风格指数 | 昨日表现 | 1 个月表现 | 6 个月表 | | --- | --- | --- | --- | | | （％） | （％） | 现（％） | | 大盘指数 | -0.06 | -3.09 | -3.93 | | 中盘指数 | -0.6 | -6.26 | -8.52 | | 小盘指数 | -0.85 | -6.2 | -2.74 | | 行业涨幅 | 昨日涨 | 1 个月涨 | 6 个月涨 | | 普钢Ⅱ | 1.64 | -3.29 | 2.87 | | 游戏Ⅱ | 1.3 | -4.5 | 2.38 | | 城商行Ⅱ | 1.24 | 3.41 | 10.11 | | 白色家电 | 1.07 | -3.32 | -4.88 | | 农商 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (一) 股东大会类型和届次 2024年年度股东大会 证券代码：603379 证券简称：三美股份 公告编号：2025-032 浙江三美化工股份有限公司 关于召开2024年年度股东大会的通知 本次股东大会所采用的表决方式是现场投票和网络投票相结合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 5 月 20 日 14 点 30 分 召开地点：浙江省武义县青年路 218 号公司办公楼会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 20 日至2025 年 5 月 20 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务 ...

证券代码：603379 证券简称：三美股份 公告编号：2025-025 内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《公司 2024 年年度报告》和《公司 2024 年年度报告摘要》。 监事会意见：《公司 2024 年年度报告》《公司 2024 年年度报告摘要》真实 地反映了公司 2024 年度的财务状况和经营成果，不存在虚假记载、误导性陈述 或重大遗漏。前述报告的编制和审议程序符合法律法规的相关规定，内容和格式 符合上海证券交易所的相关规定。同时，监事会未发现参与报告编制和审议的人 员有违反保密规定的行为。 本议案尚需提交股东大会审议。 浙江三美化工股份有限公司 第六届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"）于 2025 年 4 月 26 日以现 场表决方式在公司会议室召开第六届监事会第十七次会议。会议通知已于 2025 年 4 月 15 日以书面、电子邮件等方式向全体监事发出。本次会议应出席监事 3 人，实际出席监 ...

证券代码：603379 证券简称：三美股份 公告编号：2025-024 浙江三美化工股份有限公司 第六届董事会第十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"或"三美股份"）于 2025 年 4 月 26 日以现场结合通讯表决方式在公司会议室召开第六届董事会第十九次 会议。会议通知已于 2025 年 4 月 15 日以书面、电子邮件等方式向全体董事发出。 本次会议应出席董事 9 人，实际出席董事 9 人。本次会议由董事长胡淇翔主持， 部分高管列席会议。本次会议召开符合《公司法》和《公司章程》的有关规定。 经与会董事审议，本次会议以投票表决的方式审议通过了以下议案： 表决结果：同意 9 票，反对 0 票，弃权 0 票。 本议案在提交董事会审议前，已经公司董事会审计委员会审议并一致通过。 内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《公司 2024 年年度报告》和《公司 2024 年年度报告摘要》。 本议案尚需提交股东大会审议。 二、审议 ...